Summary
This filing is an amendment to a previous 8-K report, specifically clarifying the outcome of a shareholder vote on the frequency of advisory votes on executive compensation. Gilead Sciences, Inc. has officially announced that, following the preference expressed by its stockholders at the 2017 Annual Meeting, executive compensation will be subject to advisory votes on an annual basis. This decision aligns with the Board's recommendation and the stated preference of the shareholders. This amendment does not introduce any new material financial information or operational updates but serves to formalize the frequency of 'say-on-pay' votes. Investors should note this confirmation of an annual advisory vote, which is a standard corporate governance practice intended to provide shareholders with an ongoing voice in executive remuneration.
Key Highlights
- 1Gilead Sciences, Inc. filed an amendment (8-K/A) to its prior 8-K filing.
- 2The amendment's sole purpose is to disclose the company's decision regarding the frequency of advisory votes on executive compensation.
- 3Shareholders voted at the 2017 Annual Meeting on the frequency of these advisory votes.
- 4The majority of votes favored an '1 Year' frequency for advisory votes on executive compensation.
- 5Gilead Sciences has determined that advisory votes on executive compensation will be held annually.
- 6This decision is in accordance with the Board's recommendation and the stockholders' stated preference.
- 7No other changes were made to the original filing.